Pharming Group N.V. (AMS: PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
0.881
+0.025 (2.86%)
Dec 20, 2024, 5:35 PM CET

Pharming Group Revenue

Pharming Group had revenue of $74.85M USD in the quarter ending September 30, 2024, with 12.22% growth. This brings the company's revenue in the last twelve months to $285.75M, up 30.64% year-over-year. In the year 2023, Pharming Group had annual revenue of $245.32M with 19.30% growth.

Revenue (ttm)
$285.75M
Revenue Growth
+30.64%
P/S Ratio
2.24
Revenue / Employee
$748.02K
Employees
382
Market Cap
597.29M EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023245.32M39.69M19.30%
Dec 31, 2022205.62M6.75M3.39%
Dec 31, 2021198.87M-13.30M-6.27%
Dec 31, 2020212.17M22.79M12.03%
Jan 1, 2020189.39M54.26M40.15%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 260.09M
ASML Holding N.V. 26.24B
Unilever PLC 60.29B
Prosus N.V. 5.27B
RELX PLC 10.97B
ING Groep N.V. 17.21B
Revenue Rankings